Sir, Resistance to antimicrobials in Campylobacter can involve an efflux mechanism. Efflux pumps such as CmeB of Campylobacter can be inhibited directly by inhibitors such as Phe-Arg-b-naphthylamide (PAbN). This inhibitor has been used by others to indicate Campylobacter strains with efflux activity. 1 Insertional inactivation of cmeB was shown to increase the susceptibility of Campylobacter to a broad range of antimicrobials. 2 The aim of this study was to investigate the involvement of Overexpressed cmeB and had mutations in CmeR.
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active efflux in the antimicrobial resistance of Campylobacter isolates from Senegal. Isolates (10 Campylobacter jejuni and 1 Campylobacter coli) used in this study originated from poultry, and were isolated and characterized in a previous study (Table 1) . 3 Among the 11 isolates, 9 were resistant to quinolones and had either the Thr-86-Ile or Thr-86-Ala substitution in the A subunit of the gyrase enzyme. 3 These two amino acid changes were associated with different levels of fluoroquinolone resistance in different isolates, suggesting that another factor or factors may contribute to the resistance phenotype.
Three experiments were carried out to determine the contribution of efflux to antimicrobial resistance. First, we determined the MICs of eight antimicrobials in the presence and the absence of PAbN, added to plates to a final concentration of 40 mg/L. MICs were determined by the agar dilution method. 4 Six of the isolates were resistant to at least two antibiotic classes, showing a !4-fold increase in the MICs of nalidixic acid, erythromycin and ampicillin compared with the wild-type (NCTC 11168) ( Table 1) . PAbN caused a decrease of 16-fold in the MICs of erythromycin, nalidixic acid and gentamicin, but ciprofloxacin was only reduced by one MIC dilution (Table 1) . Second, cmeB was insertionally inactivated in five isolates by natural transformation using genomic DNA from NCTC 11168 cmeB::aph constructed previously. 2 These five isolates were chosen on the basis that they showed a !2-fold decrease in the MICs of at least two antibiotics in the presence of PAbN. Insertional inactivation of cmeB resulted in a significant decrease in the MICs of six antibiotics in the inactivated isolates compared with their parental isolates (Table 1) , thus confirming the involvement of efflux in the observed innate and selected antibiotic resistance. The most affected antimicrobials were nalidixic acid, erythromycin, ampicillin and ethidium bromide (EtBr) (!8-fold decrease in MICs). However, cmeB inactivation did not restore full susceptibility to ciprofloxacin in highly ciprofloxacin-resistant isolates P2217 and P2218 to that of the wild-type values. It is known that the Thr-86-Ile substitution in GyrA is commonly found in quinolone-resistant isolates. 3 Interestingly, cmeB inactivation in isolates P2215 and P2219, which both contain Ala-86 instead 3 and were susceptible to ciprofloxacin but resistant to nalidixic acid, conferred susceptibility to nalidixic acid. Thus, it appears that the efflux and GyrA mutation(s) work synergistically in conferring antibiotic resistance in these isolates. Third, accumulation assays with EtBr and ciprofloxacin were carried out in the presence and the absence of 100 mM carbonyl cyanide m-chlorophenyl hydrazone (CCCP), an efflux pump inhibitor. 2 Accumulation assays showed that isolates P2215, P2217, P2218 and P2219 accumulated less EtBr and ciprofloxacin than NCTC 11168 (data not shown). Addition of CCCP or inactivation of cmeB led to an increase in the accumulation of EtBr and ciprofloxacin within these isolates, suggesting that the low concentrations accumulated were due to enhanced efflux. However, accumulation assays also suggested that CmeB is not the sole CCCPsusceptible efflux pump, as CCCP was able to, albeit to a lesser extent, increase the concentration of ciprofloxacin and EtBr accumulated in all insertionally inactivated isolates.
Since mutations within CmeR (a transcriptional repressor for CmeABC) result in derepression of the cmeABC operon, leading to overexpression of cmeB, 5 we sequenced the entire cmeR genes from four isolates (P2218, P2219, P2220 and P2221) that showed an increase in MICs compared with NCTC 11168, using primers described previously. 6 Alignment of the fragments of the deduced CmeR amino acid sequences with that of NCTC 11168 identified amino acid substitutions in the C-terminal region, which is involved in substrate binding and dimerization of the repressor. All four isolates had the substitutions Gly-144-Asp and Ser-207-Gly. Isolate P2219 had two additional substitutions (Asp-123-His and Ile-205-Val), whereas P2220 had the substitutions Asp-123-His and Pro-183-Arg. Isolates P2218 and P2221 also contained the substitution Pro-183-Arg. Expression of cmeB by RT -PCR was performed for these four isolates, according to the method reported previously. 6 The data showed that in the four isolates having mutations in CmeR, there was a !4-fold increase in cmeB expression compared with NCTC 11168.
In this study, we focused on C. jejuni isolates from Senegal and confirmed a role for CmeB-mediated efflux in antibiotic resistance. Furthermore, cmeB inactivation conferred wild-type antibiotic susceptibility to two nalidixic acid-resistant isolates, which had a mutation at Ala-86 in GyrA. Mutations were observed in the C-terminal region of CmeR and this was associated with increased expression of cmeB.
